688046 藥康生物
按盤價 
14.280 +0.500 (+3.628%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.624 | 7.747 | 11.918 | 17.316 | 17.028 |
| 總資產報酬率 ROA (%) | 3.843 | 6.579 | 9.955 | 12.895 | 12.024 |
| 投入資產回報率 ROIC (%) | 4.164 | 7.128 | 11.022 | 15.361 | 15.427 | 邊際利潤分析 |
| 銷售毛利率 (%) | 63.648 | 67.611 | 71.383 | 74.330 | 72.037 |
| 營業利潤率 (%) | 19.464 | 26.308 | 33.676 | 36.381 | 34.940 |
| 息稅前利潤/營業總收入 (%) | 18.231 | 23.635 | 30.693 | 35.815 | 35.168 |
| 淨利潤/營業總收入 (%) | 19.268 | 25.541 | 31.878 | 31.725 | 29.182 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 95.691 | 84.354 | 71.657 | 72.406 | 65.201 |
| 價值變動淨收益/利潤總額(%) | 10.016 | 8.832 | 5.437 | 7.979 | 7.746 |
| 營業外收支淨額/利潤總額(%) | -0.012 | -1.488 | -0.157 | 0.035 | -0.178 | 償債能力分析 |
| 流動比率 (X) | 4.914 | 4.524 | 6.853 | 3.687 | 4.330 |
| 速動比率 (X) | 4.745 | 4.395 | 6.622 | 3.530 | 4.215 |
| 資產負債率 (%) | 16.192 | 17.572 | 12.247 | 25.491 | 25.583 |
| 帶息債務/全部投入資本 (%) | 6.857 | 6.469 | 2.625 | 5.665 | -0.053 |
| 股東權益/帶息債務 (%) | 1,315.720 | 1,389.316 | 3,596.763 | 1,552.634 | -168,913.827 |
| 股東權益/負債合計 (%) | 517.596 | 469.088 | 716.557 | 292.300 | 290.881 |
| 利息保障倍數 (X) | -14.821 | -10.332 | -10.472 | -61.858 | 121.343 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 170.932 | 131.518 | 105.860 | 95.648 | 105.992 |
| 存貨周轉天數 (天) | 76.526 | 86.251 | 96.874 | 84.413 | 73.133 |
| 備註： | 即時報價更新時間為 07/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
